{
    "Title": "Randomized Clinical Trial on Ivermectin versus Thiabendazole for the Treatment of Strongyloidiasis",
    "URL": "https://doi.org/10.1371/journal.pntd.0001254",
    "Published": "July 26, 2011",
    "Subject_Areas": [
        "Adverse reactions",
        "Strongyloidiasis",
        "Serology",
        "Chi square tests",
        "Adverse events",
        "Strongyloides stercoralis",
        "Antibodies",
        "Parasitic life cycles"
    ],
    "Authors": {
        "Zeno Bisoffi": [
            "Centre for Tropical Diseases, S. Cuore Hospital, Negrar (Verona), Italy"
        ],
        "Dora Buonfrate": [
            "Centre for Tropical Diseases, S. Cuore Hospital, Negrar (Verona), Italy"
        ],
        "Andrea Angheben": [
            "Centre for Tropical Diseases, S. Cuore Hospital, Negrar (Verona), Italy"
        ],
        "Marina Boscolo": [
            "Centre for Tropical Diseases, S. Cuore Hospital, Negrar (Verona), Italy"
        ],
        "Mariella Anselmi": [
            "Centre for Tropical Diseases, S. Cuore Hospital, Negrar (Verona), Italy"
        ],
        "Stefania Marocco": [
            "Centre for Tropical Diseases, S. Cuore Hospital, Negrar (Verona), Italy"
        ],
        "Geraldo Monteiro": [
            "Centre for Tropical Diseases, S. Cuore Hospital, Negrar (Verona), Italy"
        ],
        "Maria Gobbo": [
            "Centre for Tropical Diseases, S. Cuore Hospital, Negrar (Verona), Italy"
        ],
        "Giulia Bisoffi": [
            "Biostatistic Unit, University Hospital, Verona, Italy"
        ],
        "Federico Gobbi": [
            "Centre for Tropical Diseases, S. Cuore Hospital, Negrar (Verona), Italy"
        ]
    }
}